POC Study

POC Study. (d) If, following achievement of Milestone 3 Third Tranche in full, the Company reasonably determines that additional funding is required for completion of the Phase 2 POC Study designed to evaluate FSV7-007 as a potential treatment for cognitive impairment associated with schizophrenia (the "Phase 2 POC Study", or the "POC Study"), then the Company and ATAI shall negotiate in good faith 3 (i) any necessary updates to the Initial Clinical Development Plan (as such may be amended ... from time-to-time, attached hereto as Exhibit J), (ii) an increase to the budget necessary to complete the POC Study (any such increase, not to exceed $[***] in excess of the $[***] provided for hereunder, the "Additional Funding"), and (iii) a further amendment to this Agreement providing for such Additional Funding, the new Milestones governing such Additional Funding. View More